Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00507117 · ClinicalTrials.gov registry record · Phase 4
Ezopiclone Improves the Quality of Overnight Polysomnography
A Phase 4 study, sponsored by Walter Reed Army Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT00507117: Completed Phase 4 study, sponsored by Walter Reed Army Medical Center.
NCT00507117 is a Phase 4 study that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 300 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00507117, a Phase 4 study, has completed, sponsored by Walter Reed Army Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
Patients often have difficulty sleeping during overnight sleep testing in a lab environment. The purpose of this study is to determine if taking a sleep aid will improve sleep and therefore the quality of the sleep study.
Interventions
- DRUG Placebo control
- DRUG Lunesta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2007-03 |
| Est. Completion | 2007-10 |
| Phase | Phase 4 |
What the finished NCT00507117 record still lists
NCT00507117 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo control is the first listed.
NCT00507117 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00507117 about?
NCT00507117 is a clinical study titled "Ezopiclone Improves the Quality of Overnight Polysomnography". Patients often have difficulty sleeping during overnight sleep testing in a lab environment. The purpose of this study is to determine if taking a sleep aid will improve sleep and therefore the quality of the sleep study.
What is the current status of trial NCT00507117?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2007-03. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00507117?
The interventions under investigation include: Placebo control (DRUG), Lunesta (DRUG).
Who is sponsoring clinical trial NCT00507117?
This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00507117's enrollment target sits among peer trials
300 269th of 2000 higher than 1,709 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia